Hypokalemia is among the most frequently encountered fluid and electrolyte abnormalities in clinical medicine. The concentration of potassium (K ϩ )in the serum is a balance among intake, excretion, and distribution between the extra-and intracellular spaces. 1 Accordingly, hypokalemia may be caused by redistribution of K ϩ from serum to cells, decreased dietary intake, or excessive loss of K ϩ from the gastrointestinal track or from the kidney. Understandably, hypokalemia from excess renal or gastrointestinal loss or reduced intake would likely be associated with loss and deficiency of other ions. It is estimated that more than 50% of clinically significant hypokalemia has concomitant magnesium deficiency. Clinically, combined K ϩ and magnesium deficiency is most frequently observed in individuals receiving loop or thiazide diuretic therapy. 1 Other causes include diarrhea; alcoholism; intrinsic renal tubular transport disorders such as Bartter and Gitelman syndromes; and tubular injuries from nephrotoxic drugs, including aminoglycosides, amphotericin B, cisplatin, etc. Concomitant magnesium deficiency has long been appreciated to aggravate hypokalemia. 2 Hypokalemia associated with magnesium deficiency is often refractory to treatment with K ϩ . Co-administration of magnesium is essential for correcting the hypokalemia. The mechanism of hypokalemia in magnesium deficiency, however, remains unexplained. Here, we review existing literature on the subject to provide better understanding of the mechanism. Because of space limitations, this review cites review articles in lieu of many original publications.
Previous articles suggested that impairment of Na-K-ATPase caused by magnesium deficiency contributes to K ϩ wasting. 3, 4 Magnesium deficiency impairs Na-K-ATPase, which would decrease cellular uptake of K ϩ . 3 A decrease in cellular uptake of K ϩ , if it occurs along with increased urinary or gastrointestinal excretion, would lead to K ϩ wasting and hypokalemia. Little K ϩ is excreted by the gastrointestinal tract normally; therefore, hypokalemia in magnesium deficiency is likely associated with enhanced renal K ϩ excretion. To support this idea, Baehler et al. 5 showed that administration of magnesium decreases urinary K ϩ excretion and increases serum K ϩ levels in a patient with Bartter disease with combined hypomagnesemia and hypokalemia. Similarly, magnesium replacement alone (without K ϩ ) increases serum K ϩ levels in individuals who have hypokalemia and hypomagnesemia and receive thiazide treatment. 6 Magnesium administration decreased urinary K ϩ excretion in these individuals (Dr. Charles Pak, personal communication, UT Southwestern Medical Center at Dallas, July 13, 2007) . Moreover, magnesium infusion decreases urinary K ϩ excretion in normal individuals. 7 K ϩ is freely filtered at the glomerulus. Most of the filtered K ϩ is reabsorbed by the proximal tubule and the loop of Henle. K ϩ secretion occurs in the late distal convoluted tubule and the cortical collecting duct, which contributes in large part to urinary K ϩ excretion. 1 Kamel et al. 8 addressed the tubular site of action of magnesium by measuring the transtubular K ϩ concentration gradient (TTKG). The TTKGprovides an indirect reflection of K ϩ secretion in the distal nephron. The authors found that magnesium infusion (but not ammonium chloride infusion to correct metabolic alkalosis) reduced urinary K ϩ excretion and decreased TTKG in four of six patients with Gitelman disease and hypokalemia, hypomagnesemia, and metabolic alkalosis. Thus, magnesium replacement prevents renal K ϩ wasting, at least in part, by decreasing secretion in the distal nephron. Previous micropuncture studies also confirmed that magnesium decreases distal K ϩ secretion. 9, 10 What is the cellular mechanism for the decrease in K ϩ secretion by magnesium? In the late distal tubular and cortical collecting duct cells, K ϩ is taken up into cells across the basolateral membrane via Na-K-ATPases and secreted into luminal fluid via apical K ϩ channels. Two types of K ϩ channels mediate apical K ϩ secretion: ROMK and maxi-K channels. ROMK is an inward-rectifying K ϩ channel responsible for basal (non-flow stimulated) K ϩ secretion. 11 Inward rectification means that K ϩ ions flow in the cells through ion channels more readily than out. 12 Sodium (Na ϩ ) reabsorption via epithelial Na ϩ channel (ENaC) depolarizes the apical membrane potential, which provides the driving force for K . 13 At the physiologic extracellular K ϩ and apical membrane potential in the distal nephron, the effective intracellular concentration of Mg 2ϩ for inhibiting ROMK ranges from 0.1 to 10.0 mM, with the median concentration at approximately 1.0 mM. 13 The intracellular Mg 2ϩ concentration is estimated at 0.5 to 1.0 mM. 14 Figure 1 . K ϩ secretion in the distal nephron. K ϩ is taken up into cells across the basolateral membrane via Na-K-ATPases (blue oval) and secreted into luminal fluid via apical ROMK channels (yellow cylinder). Sodium (Na ϩ ) reabsorption via ENaC (green cylinder) depolarizes the apical membrane potential and provides the driving force for K ϩ secretion (indicated by dotted line and plus sign). Thus, increased Na ϩ delivery (indicated by black line) would stimulate K ϩ secretion. Aldosterone increases sodium reabsorption via ENaC to stimulate K ϩ secretion (indicated by red line). concentration is estimated between 10 to 20 mM. In the cytosol, Mg 2ϩ ions mainly form complexes with ATP and, to a smaller extent, with other nucleotides and enzymes. Only approximately 5% of Mg 2ϩ (0.5 to 1.0 mM) in the cytosol is free (unbound). 14 The degree of exchange of Mg 2ϩ between tissues and plasma varies greatly. It was shown in kidney and heart that 100% of intracellular Mg 2ϩ can exchange with plasma within 3 to 4 h. 15 In contrast, only approximately 10% of magnesium in brain and 25% in skeletal muscle can exchange with plasma, and the equilibrium occurs after Ն16 h. The basis for the differences is not known. The intracellular concentration of free Mg 2ϩ in renal tubules in magnesium-deficiency states has not been measured. Nevertheless, these results support the idea that intracellular Mg 2ϩ in renal tubules falls readily during magnesium deficiency. Consistent with the rapid exchange between heart and plasma, Mg 2ϩ depletion causes profound adverse effects on myocardium. 16 Several genetic disorders of magnesium homeostasis have magnesium wasting without concomitant K ϩ wasting. 17 These include familial hypomagnesemia with hypercalciuria and nephrocalcinosis, caused by mutations of a tight-junction protein Paracellin-1 in the thick ascending limb of Henle's loop, and hypomagnesemia with secondary hypocalcemia, caused by mutations of the magnesium channel TRPM6. 18, 19 In these genetic diseases of magnesium transporter disorder [17] [18] [19] and experimental models of isolated dietary magnesium deficiency, 4,10 serum K ϩ levels and urinary K ϩ excretion are normal. How do these findings reconcile with the proposed model that lowering intracellular Mg 2ϩ increases ROMK-mediated K ϩ secretion in the distal tubules? One reason for the lack of significant hypokalemia and K ϩ wasting in isolated magnesium deficiency is related to the impairment of Na-K-ATPase. Decreased cellular K ϩ uptake in the muscle and the kidney would tend to maintain serum K ϩ levels but decrease renal K ϩ secretion 4,10 ; therefore, additional factors are needed for promoting renal K ϩ excretion. Another reason is related to the fact that ROMK channels in the apical membrane of distal tubules also play an important role in regulating membrane potential. 11 An increase in the K ϩ secretion would hyperpolarize membrane potential (as a result of loss of intracellular positive charges), which decreases the driving force for outward K ϩ flux and ultimately limits the total amount of K ϩ secretion; therefore, a mere increase in ROMK activity from a low intracellular Mg 2ϩ may not be sufficient to cause a significant K ϩ wasting. Additional factors that would provide an unabating driving force for K ϩ secretion (i.e., prevent apical membrane hyperpolarization), such as an increase in distal sodium delivery and elevated aldosterone levels, are important for exacerbating K ϩ wasting in magnesium deficiency ( Figure  3) . One or both factors are present in diuretics therapy, diarrhea, alcoholism, Bartter and Gitelman syndromes, and tubular injuries from nephrotoxic drugs.
Magnesium and K ϩ are the two most abundant intracellular cations. Because of their predominant intracellular distribution, deficiency of these ions is underrecognized. Both magnesium and K ϩ are critical for stabilizing membrane potential and decreasing cell excitability. 16 Magnesium deficiency will not only exacerbate K ϩ wasting but also aggravate the adverse effects of hypokalemia on target tissues. 16 Recognition of concomitant magnesium deficiency and early treatment with magnesium are imperative for effective treatment and prevention of complications of hypokalemia. ACKNOWLEDGMENTS C.-L.H. is supported by grants from the National Institutes of Health (DK54368 and DK59530) and the Jacob Lemann Professorship in Calcium Transport at University of Texas Southwestern Medical Center and is an established investigator of the American Heart Association (0440019N).
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